Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Post-traumatic stress comorbidity in substance use disorder: machine learning analyses of phenotypic drivers
    Published on 2024-08-21
    2 years ago
  • Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective
    Published on 2024-08-21
    2 years ago
  • A new prism next to motherhood’s light: uncovering changes in neural function following childbirth
    Published on 2024-08-20
    2 years ago
  • Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry
    Published on 2024-08-19
    2 years ago
  • Basal forebrain-lateral habenula inputs and control of impulsive behavior
    Published on 2024-08-18
    2 years ago
  • Concurrent and longitudinal neurostructural correlates of irritability in children
    Published on 2024-08-17
    2 years ago
  • Distributed circuits regulating defensive state transitions: freezing, flight and fight
    Published on 2024-08-16
    2 years ago
« Previous 1 … 84 85 86 87 88 … 143 Next »
Journal of Psychopharmacology
  • Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice
    Published on 2022-05-24
    4 years ago
  • Individual and combined effects of cannabidiol and Δ9-tetrahydrocannabinol on striato-cortical connectivity in the human brain
    Published on 2022-05-21
    4 years ago
  • Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study
    Published on 2022-05-13
    4 years ago
  • Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report
    Published on 2022-05-12
    4 years ago
  • Efficacy of rasagiline monotherapy for early Parkinson disease: A systematic review and meta-analysis of randomized controlled trials
    Published on 2022-05-12
    4 years ago
  • The antidepressant effect and safety of non-intranasal esketamine: A systematic review
    Published on 2022-05-12
    4 years ago
  • Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole
    Published on 2022-05-05
    4 years ago
« Previous 1 … 84 85 86 87 88 … 154 Next »
European Neuropsychopharmacology
  • Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatment
    Published on 2022-07-11
    4 years ago
  • Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder
    Published on 2022-07-08
    4 years ago
  • Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?
    Published on 2022-07-08
    4 years ago
  • Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders
    Published on 2022-07-08
    4 years ago
  • Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan
    Published on 2022-07-07
    4 years ago
  • The potential of TAAR1 agonists in bipolar disorder
    Published on 2022-07-06
    4 years ago
  • The antipsychotic paradox: Lessons regarding determinants of premature mortality
    Published on 2022-07-03
    4 years ago
« Previous 1 … 84 85 86 87 88 … 170 Next »

   Pharma Pub